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Abstract 
The purpose of the present study was to determine the prevalence of angina pectoris in relation to various risk factors. One hundred 
cases of various types of angina pectoris in two hospitals of Narowal had been analyzed to determine the relative occurrence and 
incidence of angina pectoris, and effects of various risk factors using questionnaire. The analysis showed that silent angina pectoris 
were more prevalent (79%, n=79/100), and painful angina pectoris were less prevalent (21%, n=21/100). About 56% cases 
reported; belong to the age class 41-60 years with a higher incidence of silent angina pectoris. Angina pectoris is more prevalent in 
females (65%) as compared to males (35%). In relation to various risk factors, silent angina pectoris is the most prevalent. The 
mortality rate in this sample due to angina pectoris is 12%. All these factors contribute to the development of angina pectoris but 
only one of them may be responsible for its cause. The increasing importance of angina pectoris as a cause of morbidity presents a 
challenge. Therefore an active effort must be made to confirm or deny diagnosis. 
Keywords: Silent angina pectoris, painful angina pectoris, mortality rate, risk factors, prevalence. 
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INTRODUCTION 
Angina pectoris may be regarded as of three main 
types, stable, unstable and variant angina pectoris (Frileux 
et al., 2004). The main locations of anginal pain are the 
epigastrium, neck, back, jaw, or shoulders (Maseri et al., 
1992).The disease becomes ‘chronic’ and ‘stable’ when 
symptoms last for at least two months, without any changes 
(Kaski et al., 2011).Various factors are responsible for 
causing myocardial ischemia which include, reduction of 
coronary blood flow, abnormal constriction or deficient 
relaxation of coronary microcirculation and reduced oxygen-
carrying capacity of the blood (Nissen et al., 2007). 
Risk factors for angina pectoris consist of diabetes 
mellitus, family history of early coronary artery disease, 
hypercholesterolemia, cigarette smoking, left ventricular 
hypertrophy, obesity, elevated serum levels of lipoprotein (a) 
and homocysteine, plasminogen activator inhibitor, serum 
triglycerides, or low high-density lipoprotein (HDL) 
(Chobanian et al., 2003). Chest pain caused by means of 
myocardial ischemia. It is classified as stable or unstable 
angina. Patients with unstable angina have a much 
privileged threat of acute cardiac actions than patients with 
stable angina pectoris (Gibbons et al., 2002). 
The pathogenesis of stable angina is multifaceted and 
often, even though not always, involves flow-limiting 
epicardial coronary artery stenos that decrease the 
capability of the coronary exchange to transport suitable 
blood supply to the myocardium (Tarkin and Kaski, 2013). 
Latest studies have revealed that adenosine be able to the 
major chemical intermediary of anginal pain. During 
ischemia, ATP is deteriorate chemically to adenosine, which 
after circulation to the extracellular space, causes arteriolar 
dilation and anginal pain (Crea et al., 1990). 
Different drugs such as Aspirin, Clopidogrel, Metoprolol, 
Atenolol, Propranolol, Amlodipine, Ramipril and Ranolazine 
are used to reduce morbidity and to prevent complications 
relating to angina pectoris (Yusuf et al., 2001). Beta-
adrenergic overcrowding agents, calcium channel 
overcrowding agents, and short and long substitute nitrates 
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are the basis of therapeutic treatment for patients with 
persistent angina (Gibbons et al., 2002). Enhanced External 
Counter pulsation is one more narrative treatment for 
patients with ischemic heart disease (Arora et al., 1999). 
The present study was done to find out the occurrence and 
frequency of angina pectoris in relation to different factors 
such as age, sex, cigarette smoking, diabetes mellitus, 
obesity etc. in Narowal, Punjab. 
 
MATERIALS AND METHODS 
The prevalence of angina pectoris was determined in 
100 samples of patients. The data of patients suffering from 
angina pectoris was collected from cardiac wards of different 
hospitals of Narowal (Pakistan). A Performa was developed 
to record patient history which includes information 
regarding family unit of early coronary artery disorder, 
diabetes mellitus, obesity, cigarette smoking and 
hypercholesterolemia or systemic hypertension. Data 
obtained was tabulated using Microsoft Excel (MS Excel 
2010, Microsoft Corporation). Statistical Package for the 
Social Sciences version 16.0 (SPSS, Chicago, IL) was used 
to perform the statistical analysis. 
 
RESULTS AND DISCUSSION 
The results of our study revealed that among 100 
patients studied, a higher prevalence of silent angina 
pectoris (79%) compared to painful angina pectoris (21%) 
was found. Among 21% cases having painful angina 
pectoris, 33.33% were males and 66.66% were females. 
Females had a higher incidence of 64.55% whereas males 
had an incidence of 35.44% among 79% patients having 
silent angina pectoris (Figure 1). 
 
 
Fig. 1. Percentage of types of angina pectoris 
 
Various risk factors were studied in relation to the 
incidence of angina pectoris. These include sex, age, 
occupation, obesity, smoking, diabetes mellitus, premature 
coronary artery disease, hypertension and alcohol. Higher 
incidence of angina pectoris had been found in females 
(65%) than males (35%) (Figure 2). Similarly it has been 
found out in other studies that angina pectoris is more 
prevalent in women than in men, with a female-to-male ratio 
of 1.7:1 (Wenger et al., 2007). The frequency of atypical 
presentations is also more common among women 
compared with men. 
 
Fig. 2. Sex distribution in 100 patients of angina 
pectoris 
 
The incidence of angina pectoris was the highest (56%) 
among the age group of 41-60 years out of which females 
(58.92%) had a higher incidence than males (41.07%) 
(Figure 3). In this age group, the incidence of angina 
pectoris is higher (66.66%) as compared to other age 
groups (Soran, 2004). Previous studies have shown the 
incidence increases with grow old, getting higher starting 
approximately 8% in men and 3% in women almost 55-64 
years, to 14% in men and 8% in women aged 65-74 years, 
in England (NICE, 2011). 
 
 
Fig. 3. Age and Sex Specific Prevalence 
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The incidence of angina pectoris was the highest 
among males and females who had higher cholesterol level 
(25%) among which 68% were females and 32% were 
males (Table 1). 56% had silent angina and 44% had painful 
angina respectively (Table 2). Chobanian et al. (2003) has 
described privileged occurrence of angina pectoris between 
patients having elevated cholesterol level. Smokers had a 
higher incidence of angina pectoris (13%). The risk factor of 
smoking found in females was 38.46% and in males 61.53% 
(Table 1). 53.84 percent had silent angina and 46.15% had 
painful angina respectively (Table 2). Smokers have a 
twofold risk of angina pectoris (Berk et al., 1990). 
The incidence of angina pectoris was high amongst 
patients who had an account of premature coronary artery 
disease (22%) out of which 68.18% were females and 
31.81% were males (Table 1). Among patients having an 
account of premature coronary artery disease, the incidence 
of silent angina was 59.09% and painful angina pectoris 
40.90% respectively (Table 2). In his evaluation of risk 
factors of silent angina pectoris Crea et al. (1990) reported 
that 21.54 percent cases had history of premature coronary 
artery disease (CAD). The annual mortality rate of coronary 
heart disease 0.9-1.4% in patients with stable angina (Fox et 
al., 2006). Stable angina is the widespread medical 
demonstration of ischaemic heart disease, affecting 58% of 
patients with CAD (Lloyd-Jones et al., 2010). 
The incidence of angina pectoris in patients suffering 
from hypertension was 8%, among which 62.50% were 
females and 37.50% were males (Table 1). Among these 
patients 75%had silent angina whereas 25% had painful 
angina pectoris (Table 2). Chobanian et al. (2003) has 
described higher occurrence of angina pectoris among 
patients with hypertension. The frequency of angina pectoris 
in patients of diabetes mellitus was 4%, among which 50% 
were males and 50% were females (Table 1). Among these 
patients 75% had silent angina and 25% had painful angina 
pectoris (Table 2). Chobanian et al. (2003) has described 
elevated frequency of angina pectoris among patients 
suffering of diabetes mellitus.  
The rate of angina pectoris in patients who were 
addicted to alcohol was 16% among which 56.25% were 
males and 43.75% were females (Table 1). Among these 
patients 62.50% had silent angina and 37.50% had painful 
angina pectoris (Table 2). More alcohol intake leads towards 
a relatively weak anatomy (Frileux et al., 2004).The 
incidence of angina pectoris in obese patients was 12% 
among which 58.33% were males and 41.66% were 
females (Table 1). Among these patients 66.66% had silent 
angina and 33.33% had painful angina pectoris (Table 2). In 
his study on painful angina pectoris Wenger et al. (2007) 
found 27.31 percent obese cases. 
 
 
Table 1. Sex specific prevalence of angina pectoris in relation to various risk factors 
Risk factors 
Prevalence of angina pectoris 
Total % Male % Female % 
Cholestrol 25 32 68 
Smoking 13 61.54 38.46 
Family history 22 31.81 68.18 
Hypertension 8 37.50 62.50 
Diabetes 4 50 50 
Alcohol 16 56.25 43.75 
Obesity 12 58.33 41.66 
 
 
Table 2. Prevalence of different types of angina pectoris in relation to various risk factors 
Risk factors 
Prevalence of angina pectoris 
Total % Painful angina % Silent angina % 
Cholestrol 25 11 14 
Smoking 13 6 7 
Family history 22 9 13 
Hypertension 8 2 6 
Diabetes 4 1 3 
Alcohol 16 6 10 
Obesity 12 4 8 
M.N. Iqbal et al.                                                                                           PSM Biological Research 2016; 1(1): 06-10 
 
9 
 
Table 3. Recurrence rate of angina pectorisand mortality rate due to angina pectoris. 
Parameters Total % Male % Female % 
Recurrence rate 15 13 2 
Mortality rate 12 5 7 
 
The chief complaints reported by the patients are 
temporary pain, pressure, breadth or squeezing in the 
center of the chest or in the shoulder, neck, jaw, upper arm, 
or upper back. Other symptoms such as: faintness, 
sweating, weakness, numbness or tingling, or nausea. 
Among the patients 20.45% had painful angina pectoris and 
79.54% silent angina pectoris. Among the 100 cases 15% 
experienced recurrent out of which 86% were males 14% 
were females (Table III). In a study the overall recurrence 
rate was 20.30% (Kung et al., 2005) and smoking and age 
are the major risk factors for recurrence (Nissen et al., 
2007).  
The risk factors like smoking, family history, and obesity 
also contribute to the development of other diseases like 
hernia in human population (Iqbal et al., 2015). 
In the present study all the patients underwent surgery 
and 88% were improved and able to return to their normal 
life routines. Mortality rate due to angina pectoris was found 
to be 12% (Table III). 
 
CONCLUSION AND SUGGESTIONS 
Among two types of angina pectoris, silent angina 
pectoris is more common Pakistan. Epidemiological studies 
should be planned with the following objectives. One of 
them is to find out and to encourage the degree of the 
problem in order to inspire terms of suitable service. The 
second one is to put side by side the results with likewise 
acquired information from the residential world in search for 
extrinsic contributory factors. 
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